Clinical Trial Update: A Safety Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Painful Diabetic Neuropathy [Phase 2]

View source ↗

Summary

A Phase 2 safety study of topical clonidine gel for painful diabetic neuropathy has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Painful Diabetic Neuropathy

Drugs mentioned

• Clonidine hydrochloride topical gel 0.1% (clonidine hydrochloride topical gel)

Snippet

Sponsor: BioDelivery Sciences International | Conditions: Painful Diabetic Neuropathy, Diabetes | Phase 2 | Status: COMPLETED | Results posted: 2017-07-02